2012
DOI: 10.1016/j.reprotox.2012.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol

Abstract: ERΔ3 transgenic mice expressing a dominant negative estrogen receptor α (ERα) variant lacking the second zinc finger in the DNA binding domain were developed to examine its potential to inhibit estrogen action in vivo. To investigate if ERΔ3 expression influences uterine carcinogenesis, ERΔ3 transgenic mice were exposed to diethylstilbestrol (DES) on post-natal days 1–5. Neonatal DES treatment induced uterine adenocarcinomas in 81% of 8-month-old ERΔ3 mice compared to 49% of wild-type females (p<0.016). ERΔ3 d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 61 publications
0
6
0
Order By: Relevance
“…After NP and ER forming a ligand, they bind the response element in DNA binding domain and then induce or inhibit transcription of target genes, starting a series of estrogen-dependent physiological and biochemical processes [47]. ER has two subtypes: ER-α and ER-β; both can be expressed at different levels in normal liver tissue [48]. NP altered the expression of ER-α and ER-β in NCTC Clone 1469.…”
Section: Discussionmentioning
confidence: 99%
“…After NP and ER forming a ligand, they bind the response element in DNA binding domain and then induce or inhibit transcription of target genes, starting a series of estrogen-dependent physiological and biochemical processes [47]. ER has two subtypes: ER-α and ER-β; both can be expressed at different levels in normal liver tissue [48]. NP altered the expression of ER-α and ER-β in NCTC Clone 1469.…”
Section: Discussionmentioning
confidence: 99%
“…Higher circulating 17β-estradiol levels and non-classical signaling may be related to the earlier incidence of uterine cancer in transgenic mice. These findings indicate that expression of the ERα variant can influence determining events in uterine cancer development and its natural occurrence in the human uterus would unlikely be protective [71].…”
Section: Journal Of Clinical Epigenetics Issn 2472-1158mentioning
confidence: 96%
“…DES (1 mg/kg/day) on PND1-5 is an established dose with high efficacy ($90% uterine cancer), which we used to reduce variability in our endpoints to understand the molecular mechanisms underlying endometrial carcinogenesis. Sample sizes were calculated on the basis of previously published studies showing that 45% of FVB/N mice exposed neonatally to DES develop cancer by 8 months of age (31,32). We estimated that using 12 mice per exposure group and genotype would allow us to detect a 45% difference in cancer incidence (one-sided 0.05 level of significance with 80% power) beginning at 6 months.…”
Section: Animalsmentioning
confidence: 99%